Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)
Italy
· Delayed Price · Currency is EUR 291.90
0.00 (0.00%)
At close: Aug 8, 2025, 5:30 PM CET
Madrigal Pharmaceuticals Revenue
Madrigal Pharmaceuticals had revenue of $212.80M USD in the quarter ending June 30, 2025, with 1,353.76% growth. This brings the company's revenue in the last twelve months to $515.55M, up 3,421.98% year-over-year. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.
Revenue (ttm)
$515.55M
Revenue Growth
+3,421.98%
P/S Ratio
16.19
Revenue / Employee
$976.41K
Employees
528
Market Cap
7.11B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.82B |
| Intesa Sanpaolo | 25.58B |
| Enel SpA | 77.79B |
| Ferrari | 6.96B |
| Assicurazioni Generali | 56.77B |
| Eni S.p.A. | 87.03B |
| Leonardo S.p.a. | 18.70B |
| Poste Italiane | 13.75B |